CAS No.298-81-7,8-Methoxypsoralen Suppliers,MSDS download

Products Categories

Pharmaceutical (94)
Others (40)
Plant Extract (34)
Organic Chemicals (27)
Reagent (7)
(2)
Materials (1)

Basic Information

Molecular Structure:
CAS No.:	298-81-7
Name:	8-Methoxypsoralen
Article Data:	37

Formula:	C₁₂H₈O₄
Molecular Weight:	216.193
Synonyms:	5-Benzofuranacrylicacid, 6-hydroxy-7-methoxy-, d-lactone (7CI);8-MOP;8-MP;8-Methoxy-6,7-furanocoumarin;8-Methoxy[furano-3',2':6,7-coumarin];8-Methoxypsoralene;Ammodin;Ammoidin;Deltapsoralen;Geroxalen;Meladinin;Meladinine;Meladoxen;Meloxine;Methoxa-Dome;Methoxsalen;Methoxsalene;NSC 45923;New-Meladinin;Oxsoralen;OxsoralenLotion;Oxsoralen-Ultra;Oxypsoralen;Puvalen;Puvamet;Uvadex;Xanthotoxin;Xanthotoxine;
EINECS:	206-066-9
Density:	1.368 g/cm³
Melting Point:	148-150 °C(lit.)
Boiling Point:	414.795 °C at 760 mmHg
Flash Point:	204.661 °C
Solubility:	practically insoluble in water
Appearance:	Crystalline Solid
Hazard Symbols:	Xn, T
Risk Codes:	22-43-46-45-34
Safety:	36/37-53-45-36/37/39-26
Transport Information:	UN 3216
PSA:	52.58000
LogP:	2.54780

Total:153 Page 1 of 5 1 2 3 4 5 Next>>

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 298-81-7

Consensus Reports

NTP 10th Report on Carcinogens. IARC Cancer Review: Group 1 IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of chemicals to Man . 7 ,1987,p. 243.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Human Inadequate Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of chemicals to Man . 24 ,1980,p. 101.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Inadequate Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of chemicals to Man . 24 ,1980,p. 101.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) . Reported in EPA TSCA Inventory. EPA Genetic Toxicology Program.

Specification

The Xanthotoxin is an organic compound with the formula C₁₂H₈O₄. The IUPAC name of this chemical is 9-methoxyfuro[3,2-g]chromen-7-one. With the CAS registry number 298-81-7, it is also named as 6-Hydroxy-7-methoxy-5-benzofuranacrylic Acid d-Lactone. The product's categories are Intermediates & Fine Chemicals; Pharmaceuticals; Cytochrome P450 isozyme. Besides, it is a crystalline solid, which can be used in treatment of psoriasis and mycosis fungoides.

Physical properties about Xanthotoxin are: (1)ACD/LogP: 1.52; (2)ACD/LogD (pH 5.5): 1.523; (3)ACD/LogD (pH 7.4): 1.523; (4)ACD/BCF (pH 5.5): 8.463; (5)ACD/BCF (pH 7.4): 8.463; (6)ACD/KOC (pH 5.5): 160.531; (7)ACD/KOC (pH 7.4): 160.531; (8)#H bond acceptors: 4; (9)#Freely Rotating Bonds: 1; (10)Polar Surface Area: 48.67 Å²; (11)Index of Refraction: 1.635; (12)Molar Refractivity: 56.587 cm³; (13)Molar Volume: 158.01 cm³; (14)Polarizability: 22.433×10^-24cm³; (15)Surface Tension: 52.035 dyne/cm; (16)Density: 1.368 g/cm³; (17)Flash Point: 204.661 °C; (18)Enthalpy of Vaporization: 66.778 kJ/mol; (19)Boiling Point: 414.795 °C at 760 mmHg.

Preparation: this chemical can be prepared by 9-methoxy-7-oxo-7H-furo[3,2-g]chromene-6-carboxylic acid. This reaction will need reagent Copper powder, quinoline. The reaction time is 60 min by heating. The yield is about 72%.

Uses of Xanthotoxin: it can be used to produce 9-methoxy-furo[3,2-g]chromene-7-thione. It will need reagent phosphorus (V)-sulfide and xylene.

When you are using this chemical, please be cautious about it as the following:
It is harmful if swallowed and can cause burns and cancer. Please avoid exposure - obtain special instructions before use. In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. Besides, this chemical may cause sensitisation by skin contact and may cause sensitisation by inhalation and skin contact. When you are using it, wear suitable gloves and eye/face protection. In case of accident or if you feel unwell seek medical advice immediately (show the label where possible).

You can still convert the following datas into molecular structure:
(1)SMILES: COc1c2c(ccc(=O)o2)cc3c1occ3
(2)InChI: InChI=1/C12H8O4/c1-14-12-10-8(4-5-15-10)6-7-2-3-9(13)16-11(7)12/h2-6H,1H3
(3)InChIKey: QXKHYNVANLEOEG-UHFFFAOYAV
(4)Std. InChI: InChI=1S/C12H8O4/c1-14-12-10-8(4-5-15-10)6-7-2-3-9(13)16-11(7)12/h2-6H,1H3
(5)Std. InChIKey: QXKHYNVANLEOEG-UHFFFAOYSA-N

The toxicity data is as follows:

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
guinea pig	LD50	oral	505mg/kg (505mg/kg)		"Psoralens in Cosmetics and Dermatology, Proceedings of the International Symposium, Paris, 1981," Cahn, J., et al., eds., Paris, Pergamon Press France, 1981Vol. -, Pg. 303, 1981.
mouse	LD50	intraperitoneal	250mg/kg (250mg/kg)	BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) BEHAVIORAL: ATAXIA	Drug and Chemical Toxicology. Vol. 2, Pg. 309, 1979.
mouse	LD50	oral	423mg/kg (423mg/kg)	BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) BEHAVIORAL: ATAXIA	Drug and Chemical Toxicology. Vol. 2, Pg. 309, 1979.
mouse	LD50	subcutaneous	860mg/kg (860mg/kg)		Drugs in Japan Vol. 6, Pg. 837, 1982.
rat	LD50	intraperitoneal	158mg/kg (158mg/kg)		Drug and Chemical Toxicology. Vol. 2, Pg. 309, 1979.
rat	LD50	oral	791mg/kg (791mg/kg)	BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) BEHAVIORAL: ATAXIA	Drug and Chemical Toxicology. Vol. 2, Pg. 309, 1979.
rat	LD50	subcutaneous	1880mg/kg (1880mg/kg)		Drugs in Japan Vol. -, Pg. 1372, 1995.